ClinicalTrials.Veeva

Menu

Overactive Bladder (OAB) Drink Advice Study

R

Radboud University Medical Center

Status

Withdrawn

Conditions

Overactive Bladder Syndrome

Treatments

Dietary Supplement: water

Study type

Interventional

Funder types

Other

Identifiers

NCT00982241
OABdrinkstudy

Details and patient eligibility

About

The researchers want to investigate how fluid intake influences the symptoms of OAB. The researchers will recruit 45 patients with OAB and randomize them (blind) in 3 groups (low/normal/high fluid intake). Patients will follow this drink pattern for 2-5 days, while filling in an standard micturation diary for 2 days. This micturation diary is coupled to: collection of multiple urine samples, urine pH measurements, and a Perception of Intensity of Urgency Scale (PPIUS) scoring table. All this is collected by the patients themselves. Urine samples will be analysed for osmolality by the clinical chemistry department.

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • OAB patients

Exclusion criteria

  • benign prostatic hyperplasia
  • neurogenic detrusor overactivity
  • urine tract infection
  • anticholinergics
  • intravesical botulin toxin
  • cardiac failure
  • renal insufficiency
  • sacral neurostimulation
  • percutaneous neurostimulation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 3 patient groups

normal fluid intake
Active Comparator group
Description:
1500 ml /day (+/- 300 ml) for 2,5 days
Treatment:
Dietary Supplement: water
high fluid intake
Active Comparator group
Description:
2400 ml/day (+/- 300 ml )for 2,5 days
Treatment:
Dietary Supplement: water
low fluid intake
Active Comparator group
Description:
fluid intake 900 ml/day (+/- 300ml) for 2,5 days
Treatment:
Dietary Supplement: water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems